↓ Skip to main content

Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147

Overview of attention for article published in Frontiers in immunology, December 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Tocilizumab (TCZ) Decreases Angiogenesis in Rheumatoid Arthritis Through Its Regulatory Effect on miR-146a-5p and EMMPRIN/CD147
Published in
Frontiers in immunology, December 2021
DOI 10.3389/fimmu.2021.739592
Pubmed ID
Authors

Devy Zisman, Mirna Safieh, Elina Simanovich, Joy Feld, Amalia Kinarty, Liron Zisman, Tal Gazitt, Amir Haddad, Muna Elias, Itzhak Rosner, Lisa Kaly, Michal A. Rahat

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 15%
Professor > Associate Professor 2 15%
Student > Master 2 15%
Student > Doctoral Student 1 8%
Other 1 8%
Other 0 0%
Unknown 5 38%
Readers by discipline Count As %
Immunology and Microbiology 2 15%
Medicine and Dentistry 2 15%
Biochemistry, Genetics and Molecular Biology 1 8%
Unspecified 1 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 8%
Other 1 8%
Unknown 5 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 January 2022.
All research outputs
#22,774,430
of 25,392,582 outputs
Outputs from Frontiers in immunology
#27,442
of 31,541 outputs
Outputs of similar age
#437,190
of 512,296 outputs
Outputs of similar age from Frontiers in immunology
#1,318
of 1,492 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 31,541 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 512,296 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,492 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.